Year in review · from our October 2026 register copy
NAFDAC registrations in 2024
By the approval dates our October 2026 copy of the Greenbook records, 1,362 products were approved onto the register in 2024 — 1,049 of them in Drugs. 100% of the class of 2024 is still active in our copy today.
By category
- Drugs— 1,049
- Medical devices— 254
- Herbals and Nutraceuticals— 30
- Vaccines and Biologics— 19
- Veterinary— 8
- Uncategorised— 2
Month by month
Approvals are batched — quiet months and spikes are the register's own rhythm, not demand.
Who registered the most
- 1.Fidson Healthcare— 28 approvals
- 2.Uni-Medical Healthcare— 20 approvals
- 3.Tuyil Pharmaceutical Industries— 19 approvals
- 4.Nel Apex Global— 17 approvals
- 5.Phillips Pharmaceuticals (Nigeria)— 16 approvals
- 6.Shalina Healthcare Nigeria— 16 approvals
- 7.Unicure Pharmaceuticals— 15 approvals
- 8.Emzor Pharmaceutical Industries— 14 approvals
- 9.Me Cure Industries— 14 approvals
- 10.Novartis Nigeria— 14 approvals
Where the year's medicines were made
Factory countries recorded on 1,048 of the year's 1,049 drug approvals.
Month-to-month changes — new listings, renewals, lapses — live on the NAFDAC Registry Watch, updated with every register refresh.
Other years
Counted from the approval dates in our dated copy of the public NAFDAC Greenbook. The register backfills approval entries long after the fact, so a year's count can still grow after it ends — which is also why the current year has no page until it completes. Registration counts are not market share or sales.